53 Clomiphene Citrate for Poor Responder Women Undergoing Ivf/Icsi Treatment Cycles: Randomised Controlled Study

Youssef, Mohamed; Mohsen, Iman Abdel; Khattab, S.; Ashmawi, H. El; Darwish, Atef M.; Foutouh, Ismail Aboul

doi:10.1016/s1472-6483(10)62471-6

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Twenty‐two studies (from 30 records) were included in the present review. The study flow diagram is shown in Figure S1.…”

Section: Resultsmentioning

confidence: 99%

“…Seven studies (from 11 records) evaluated CC in women with expected POR: one study used CC alone, two studies used CC and a lower FSH dose and four studies used CC, a lower FSH dose and a GnRH antagonist. Nine studies (from 11 records) evaluated CC in other women: seven studies used CC and a lower FSH dose and two studies used CC, a lower FSH dose and a GnRH antagonist.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Clomiphene citrate and letrozole to reduce follicle‐stimulating hormone consumption during ovarian stimulation: systematic review and meta‐analysis

Bechtejew

Nadai

Nastri³

et al. 2017

Ultrasound in Obstet & Gyne

View full text Add to dashboard Cite

The use of CC to reduce FSH consumption in women with expected poor ovarian response has the advantage of providing similar reproductive outcomes with reduced costs. For the other women, the use of CC for reducing FSH consumption has the additional advantage of reducing OHSS, but also reduces the total number of oocytes retrieved. More studies are needed to evaluate the effect of LTZ for the same purpose. Future studies should focus on cumulative pregnancy per oocyte retrieval, patient dissatisfaction and agreement to repeat the cycle if not pregnant, which are important outcomes for clinical decisions. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.

show abstract

“…Twenty‐two studies (from 30 records) were included in the present review. The study flow diagram is shown in Figure S1.…”

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Clomiphene citrate and letrozole to reduce follicle‐stimulating hormone consumption during ovarian stimulation: systematic review and meta‐analysis

Bechtejew

Nadai

Nastri³

et al. 2017

Ultrasound in Obstet & Gyne

View full text Add to dashboard Cite

show abstract

“…Sete estudos (de 11 registros) avaliaram CC em mulheres em que se espera má resposta ovariana: um estudo usando CC isolado (Ragni 2012) (110,119,120) , dois estudos utilizaram CC + baixa dose de FSH (Ashrafi 2005 (96) , Karimzadeh 2010 (103,121) ), e quatro estudos com CC + baixa dose de FSH + antagonista GnRH (Fujimoto 2014 (116) , Martínez 200 (107) , Revelli 2014 (111) , Youssef 2011 (114,122) ).…”

Section: Identificação Do Estudounclassified

Clomifeno e letrozol para estimulação ovariana controlada em técnicas de reprodução assistida: revisão sistematizada e meta-análise

Bechtejew¹,

Martins²

View full text Add to dashboard Cite

show abstract

53 Clomiphene Citrate for Poor Responder Women Undergoing Ivf/Icsi Treatment Cycles: Randomised Controlled Study

Cited by 2 publications

References 0 publications

Clomiphene citrate and letrozole to reduce follicle‐stimulating hormone consumption during ovarian stimulation: systematic review and meta‐analysis

Clomiphene citrate and letrozole to reduce follicle‐stimulating hormone consumption during ovarian stimulation: systematic review and meta‐analysis

Clomifeno e letrozol para estimulação ovariana controlada em técnicas de reprodução assistida: revisão sistematizada e meta-análise

Contact Info

Product

Resources

About